Lepu Medical Technology (Beijing) Co., Ltd. received Niederer Kraft Frey’s advice prior to its successful USD 224 million offering and listing of global depositary receipts on SIX Swiss Exchange as part of the China-Switzerland Stock Connect Program.
Lepu is a Chinese company that offers medications, medical equipment, and services for every stage of managing cardiovascular disease. The business, whose A Shares are traded on the Shenzhen Stock Exchange, is to use the net proceeds of the offering to finance its international expansion and global R&D projects. Joint global coordinators for the transaction were Credit Suisse AG, CLSA Limited, and China International Capital Corporation (UK) Limited. The GDRs began trading on the SIX Swiss Exchange on September 21, 2022.
Leading the NKF team were partners Daniel Bono (Capital Markets) and Philippe Weber (Corporate/Capital Markets), as well as counsel Franziska Albers-Schoenberg (Capital Markets). Markus Kronauer, a partner, and senior associate Shu Bernet-Zhang (Corporate/Capital Markets) completed the team (Tax).
